Bladder Cancer

DC 7528Genitourinary38 CFR 4.115b, DC 7528

Cancer of the bladder. The VA assigns a 100% rating during active treatment, then rates based on residual effects like voiding dysfunction after treatment ends.

How the VA rates this condition

The VA rates this condition based on the type and intensity of treatment you require. Higher ratings correspond to more aggressive treatment regimens, such as daily medication, insulin dependence, or the need for ongoing medical management.

Diagnostic code

DC 7528

Rating range

0% – 100%

Rating levels

Rating criteria are defined in 38 CFR 4.115b, DC 7528. This guide presents a plain-language summary and is not a substitute for the full regulatory text. Always consult a VSO or VA-accredited attorney for case-specific advice.

Rating Levels

You are undergoing active treatment for bladder cancer — surgery, radiation, chemotherapy, or other therapeutic procedure. The VA assigns a mandatory 100% rating during active malignancy. Re-evaluation occurs 6 months after treatment ends.

What the VA looks for

Active bladder cancer diagnosis (pathology report)
Undergoing surgery, radiation, or chemotherapy
Oncology treatment records
Imaging confirming malignancy

Common Pitfalls

⚠Not filing immediately upon diagnosis to capture the automatic 100% rating during active treatment.
⚠Not requesting a re-evaluation after treatment to document residual dysfunction.
⚠Not documenting all voiding dysfunction (frequency, leakage, need for absorbent materials).
⚠Bladder cancer is common among veterans with Agent Orange exposure or burn pit exposure — document these service connections.